LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
BT-20 GSK1059615
1.11
uM
LJP5
 1
E03
 72
hr
 1334 830 3930 0.2112 -0.2628
BT-20 GSK1059615
1.11
uM
LJP5
 2
E03
 72
hr
 1334 733 4051 0.1809 -0.3121
BT-20 GSK1059615
1.11
uM
LJP5
 3
E03
 72
hr
 1334 761 4117 0.1848 -0.2923
BT-20 GSK1059615
3.33
uM
LJP6
 1
C02
 72
hr
 1334 295 3955 0.0746 -0.6183
BT-20 GSK1059615
3.33
uM
LJP6
 2
C02
 72
hr
 1334 635 3899 0.1629 -0.3814
BT-20 GSK1059615
3.33
uM
LJP6
 3
C02
 72
hr
 1334 950 3921 0.2423 -0.1964
BT-20 GSK1059615
3.33
uM
LJP5
 1
E02
 72
hr
 1334 402 3930 0.1023 -0.5370
BT-20 GSK1059615
3.33
uM
LJP5
 2
E02
 72
hr
 1334 392 4051 0.0968 -0.5346
BT-20 GSK1059615
3.33
uM
LJP5
 3
E02
 72
hr
 1334 491 4117 0.1192 -0.4595
BT-20 GSK1059615
10
uM
LJP6
 1
C01
 72
hr
 1334 228 3955 0.0576 -0.6761
BT-20 GSK1059615
10
uM
LJP6
 2
C01
 72
hr
 1334 353 3899 0.0905 -0.5768
BT-20 GSK1059615
10
uM
LJP6
 3
C01
 72
hr
 1334 355 3921 0.0905 -0.5733
BT-20 GSK1059615
10
uM
LJP5
 1
E01
 72
hr
 1334 443 3930 0.1127 -0.5072
BT-20 GSK1059615
10
uM
LJP5
 2
E01
 72
hr
 1334 496 4051 0.1224 -0.4610
BT-20 GSK1059615
10
uM
LJP5
 3
E01
 72
hr
 1334 482 4117 0.1171 -0.4656
BT-20 Brivanib
0.04
uM
LJP5
 1
P18
 72
hr
 1334 4099 3930 1.0428 1.0545
BT-20 Brivanib
0.04
uM
LJP5
 2
P18
 72
hr
 1334 4016 4051 0.9913 0.9892
BT-20 Brivanib
0.04
uM
LJP5
 3
P18
 72
hr
 1334 3909 4117 0.9493 0.9370
BT-20 Brivanib
0.12
uM
LJP5
 1
P17
 72
hr
 1334 3855 3930 0.9807 0.9752
BT-20 Brivanib
0.12
uM
LJP5
 2
P17
 72
hr
 1334 4006 4051 0.9889 0.9861
BT-20 Brivanib
0.12
uM
LJP5
 3
P17
 72
hr
 1334 3732 4117 0.9063 0.8826
BT-20 Brivanib
0.37
uM
LJP5
 1
P16
 72
hr
 1334 3911 3930 0.9950 0.9935
BT-20 Brivanib
0.37
uM
LJP5
 2
P16
 72
hr
 1334 3871 4051 0.9556 0.9440
BT-20 Brivanib
0.37
uM
LJP5
 3
P16
 72
hr
 1334 4006 4117 0.9729 0.9665
BT-20 Brivanib
1.11
uM
LJP5
 1
P15
 72
hr
 1334 3799 3930 0.9665 0.9567